Makov

Rediff.com » News » Makov

News for Makov

Business

'Premature to talk of changes in Ranbaxy top brass now'

Sun Pharmaceutical Industries will take a call on whether to shut Ranbaxy's troubled factories or make changes in the top management of the latter only after its $4-billion acquisition deal is......

Meet the man behind the Sun Pharma-Ranbaxy deal

Israel Makov, the 75-year-old chairman of Sun Pharmaceutical, pushed through the deal to acquire Ranbaxy at a six-hour board meeting on Sunday. Makov’s contribution was not limited to......

Sun chief hopes the worst is over for Ranbaxy

Sun Pharma would have to do a lot of work to get USFDA to revoke the ban on Ranbaxy facilities but it has not put any time-frame for this, company Chairman Israel Makov said. Sun Pharma's......

Benefit of Ranbaxy deal to accrue in few years: Sun Pharma

It will take a ‘few years’ for Sun Pharma to realise the benefits of its $4 billion takeover of Ranbaxy, said the company's Chairman Israel Makov, terming the deal as a ‘complex......

Sun Pharma, Mahindras in India's top-10 club

In May 2012, when Dilip Shanghvi announced he was relinquishing his job as chairman of Sun Pharmaceuticals to make way for Israel Makov, former CEO of Teva Pharmaceuticals, everyone wondered why......

Makov

News for Makov

'Premature to talk of changes in Ranbaxy top brass now'

Meet the man behind the Sun Pharma-Ranbaxy deal

Sun chief hopes the worst is over for Ranbaxy

Benefit of Ranbaxy deal to accrue in few years: Sun Pharma

Sun Pharma, Mahindras in India's top-10 club

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS